
NEXT GENERATION PEPTIDE DRUGS FAVOR SYNTHETIC, NOT RECOMBINANT MANUFACTURING
The advent of new drugs targeting diabetes, obesity, and cardiovascular diseases has sparked a surge in the demand for polypeptide manufacturing. This surge, in turn, has propelled an industrial intensification…












